Tempus AI investors sue for losses between Aug 6, 2024 and May 27, 2025.
PorAinvest
viernes, 8 de agosto de 2025, 8:11 am ET1 min de lectura
AZN--
The class action lawsuit alleges that Tempus AI made false and/or misleading statements and/or failed to disclose several significant issues during the Class Period. These include:
1. Inflation of contract agreements with related parties, often including non-binding opt-ins and self-funded agreements.
2. Risks associated with Tempus AI's joint venture with SoftBank Group Corporation, which gave the appearance of "round-tripping" capital to create revenue.
3. Aggressive and potentially unethical billing practices of Tempus AI-acquired Ambry Genetics Corporation.
4. A questionable "pass-through payment" arrangement with AstraZeneca PLC, which reduced Tempus AI's financial commitments.
5. Weaknesses in core operations and revenue prospects revealed by these issues.
The lawsuit also notes that on May 28, 2025, Spruce Point Capital Management, LLC issued a report on Tempus AI that raised numerous red flags, leading to a significant drop in Tempus AI's stock price by more than 19% [1].
Investors who suffered substantial losses and wish to serve as lead plaintiff can provide their information online at [Robbins Geller Rudman & Dowd LLP's website](https://www.rgrdlaw.com/cases-tempus-ai-inc-class-action-lawsuit-tem.html) or contact attorneys J.C. Sanchez or Jennifer N. Caringal by calling 800/449-4900 or via email at [Robbins Geller Rudman & Dowd LLP](mailto:).
Another law firm, Bragar Eagel & Squire, P.C., has also announced a class action lawsuit against Tempus AI, Inc. Investors have until August 11, 2025 to apply to the Court to be appointed as lead plaintiff. They can contact Brandon Walker or Marion Passmore at (212) 355-4648 or via email at [Bragar Eagel & Squire, P.C.](mailto:).
References:
[1] https://www.prnewswire.com/news-releases/investor-deadline-monday-robbins-geller-rudman--dowd-llp-announces-that-tempus-ai-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit---tem-302522691.html
TEM--
Tempus AI common stock purchasers between August 6, 2024 and May 27, 2025 can seek lead plaintiff appointment by August 12, 2025 in the Tempus AI class action lawsuit. The lawsuit alleges violations of the Securities Exchange Act of 1934 against Tempus AI and its executives. Interested parties can contact Robbins Geller or provide information online.
San Diego, Aug. 6, 2025 — Robbins Geller Rudman & Dowd LLP has announced that investors who purchased Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, have until Tuesday, August 12, 2025 to seek appointment as lead plaintiff in the Tempus AI class action lawsuit. The lawsuit, captioned Shouse v. Tempus AI, Inc., No. 25-cv-06534 (N.D. Ill.), alleges violations of the Securities Exchange Act of 1934 against Tempus AI and its executives.The class action lawsuit alleges that Tempus AI made false and/or misleading statements and/or failed to disclose several significant issues during the Class Period. These include:
1. Inflation of contract agreements with related parties, often including non-binding opt-ins and self-funded agreements.
2. Risks associated with Tempus AI's joint venture with SoftBank Group Corporation, which gave the appearance of "round-tripping" capital to create revenue.
3. Aggressive and potentially unethical billing practices of Tempus AI-acquired Ambry Genetics Corporation.
4. A questionable "pass-through payment" arrangement with AstraZeneca PLC, which reduced Tempus AI's financial commitments.
5. Weaknesses in core operations and revenue prospects revealed by these issues.
The lawsuit also notes that on May 28, 2025, Spruce Point Capital Management, LLC issued a report on Tempus AI that raised numerous red flags, leading to a significant drop in Tempus AI's stock price by more than 19% [1].
Investors who suffered substantial losses and wish to serve as lead plaintiff can provide their information online at [Robbins Geller Rudman & Dowd LLP's website](https://www.rgrdlaw.com/cases-tempus-ai-inc-class-action-lawsuit-tem.html) or contact attorneys J.C. Sanchez or Jennifer N. Caringal by calling 800/449-4900 or via email at [Robbins Geller Rudman & Dowd LLP](mailto:).
Another law firm, Bragar Eagel & Squire, P.C., has also announced a class action lawsuit against Tempus AI, Inc. Investors have until August 11, 2025 to apply to the Court to be appointed as lead plaintiff. They can contact Brandon Walker or Marion Passmore at (212) 355-4648 or via email at [Bragar Eagel & Squire, P.C.](mailto:).
References:
[1] https://www.prnewswire.com/news-releases/investor-deadline-monday-robbins-geller-rudman--dowd-llp-announces-that-tempus-ai-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit---tem-302522691.html
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios